Terazosin recalls
The FDA has published 3 recalls involving Terazosin since 2013. The latest was reported on 29 Jan 2014. Most were for packaging defects. Teva Pharmaceuticals USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 Jan 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why terazosin is recalled
Companies
By year
All terazosin recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Terazosin HCL, Capsule, 5 mg recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Terazosin Hydrochloride Capsules,10 mg recalled | Teva Pharmaceuticals USA | Packaging Defects | Nationwide |
| Drug | CLASS II | Terazosin Hydrochloride Capsules, 2 mg recalled | Teva Pharmaceuticals USA | Packaging Defects | Nationwide |
Should you stop taking Terazosin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.